About Oxyphen
Oxyphen is a Healthcare company based in Wetzikon (Switzerland) founded in 1953, and was acquired by Filtration Group in May 2020. Microporous track-etched membranes are manufactured for filtration and analysis applications. Its chief executive, as recorded, is Annette Heusser. Its focus areas include Traditional Medical Devices. Its legal entity is Oxyphen GmbH.
Company details
Oxyphen was established in 1953 in Wetzikon, Switzerland, where microporous track-etched membranes are produced for use in scientific research, environmental monitoring, and industrial filtration. Operations focus on precision manufacturing processes, with products distributed to international clients in the biotechnology and materials sectors. Leadership is provided by CEO Annette Heusser, and the companys expertise in membrane technology has been built over seven decades in a specialized European facility.
- Headquarters Wetzikon, Switzerland
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website oxyphen.com
- Acquired by Filtration Group (May 2020)
- Legal Name Oxyphen Gmbh
- Investors
- Acquired byFiltration Group
(May 2020)
Investors in Oxyphen
Oxyphen has secured backing from 1 investor. Prominent investors backing the company include Filtration Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Filtration products and solutions are manufactured for diverse industries. | 1942 | filtrationgroup.com | Austin, United States |
Investor details for Oxyphen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Oxyphen
1 people are tracked at Oxyphen (1 in leadership).
| Name | Role | Group |
|---|---|---|
Annette Heusser | CEO | Leadership |
Complete people profiles for Oxyphen
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Oxyphen
2 dated milestones of Oxyphen across 67 years, from founding to its latest funding, stage changes and deals.
- Founded Oxyphen is founded.
- Exit Acquired by Filtration Group.
Web traffic of Oxyphen
The website of Oxyphen (oxyphen.com) receives about 1.9K visits a month.
- Monthly visits1.9K
▼ 6.1% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Oxyphen
Oxyphen was founded in 1953.
Oxyphen is headquartered in Wetzikon, Switzerland. It is registered at Wetzikon, Zurich, Switzerland.
Annette Heusser is the CEO of Oxyphen, as recorded in our data.
Oxyphen was established in 1953 in Wetzikon, Switzerland, where microporous track-etched membranes are produced for use in scientific research, environmental monitoring, and industrial filtration. Operations focus on precision manufacturing processes, with products distributed to international clients in the biotechnology and materials sectors. Leadership is provided by CEO Annette Heusser, and the companys expertise in membrane technology has been built over seven decades in a specialized European facility.
Oxyphen has 1 investor. Key investors include Filtration Group.
Oxyphen operates through Oxyphen Gmbh.
Yes. Oxyphen was acquired by Filtration Group in May 2020.